ACCESSION: MSBNK-SMB_Measured-HSA015P0086004
RECORD_TITLE: Characterized; Piperidine; LC-ESI-QFT; MS2; POSITIVE; generated fron DDA dataset
DATE: 2025.03.05 (Averaged 2025.02.21, Processed 2025.02.21, Annotated 2025.03.05, Curated 2025.03.05)
AUTHORS: Shin-MassBank project
LICENSE: CC BY-NC-SA
PUBLICATION: Ruggiero et al. Int J Cancer. 2023, 153, 1, 210-223
COMMENT: This is an averaged mass spectra data created by averaging product ion scan data obtained from the following DDA dataset.
COMMENT: The metabolite structure was characterized at Level 3 automatically. One of the possible structures is shown in the record.
COMMENT: REPOSITORY MetaboLights
COMMENT: DATASET_ID MTBLS6402
COMMENT: DATASET_TITLE FSCN1 as a new druggable target in adrenocortical carcinoma
COMMENT: DATASET_AUTHORS Andrei Turtoi, Enzo Lalli
COMMENT: MS1_M/Z_AVERAGED_THRES 5.000
COMMENT: MS2_M/Z_AVERAGED_THRES 5.000
COMMENT: DATASET_FILE_NUM 27
COMMENT: NUM_AVERAGED_SPEC 17
COMMENT: RAW_SPEC {'EL22_pos_1511': {'bp': 224038.0, 'sum': 1175994.0}, 'EL23_pos_1503': {'bp': 209148.0, 'sum': 1310059.0}, 'EL15_pos_1505': {'bp': 174299.0, 'sum': 1060970.0}, 'EL08_pos_1505': {'bp': 164531.0, 'sum': 1105998.0}, 'EL04_pos_1510': {'bp': 164452.0, 'sum': 1087469.0}, 'EL12_pos_1505': {'bp': 162948.0, 'sum': 901446.0}, 'EL17_pos_1501': {'bp': 162449.0, 'sum': 1079567.0}, 'EL21_pos_1502': {'bp': 158037.0, 'sum': 972307.0}, 'EL19_pos_1516': {'bp': 146455.0, 'sum': 983666.0}, 'EL07_pos_1505': {'bp': 129809.0, 'sum': 959251.0}, 'EL20_pos_1501': {'bp': 129587.0, 'sum': 929579.0}, 'EL10_pos_1505': {'bp': 127877.0, 'sum': 870494.0}, 'EL09_pos_1508': {'bp': 127866.0, 'sum': 952646.0}, 'EL14_pos_1515': {'bp': 123574.0, 'sum': 770670.0}, 'EL11_pos_1505': {'bp': 120240.0, 'sum': 915637.0}, 'EL01_pos_1509': {'bp': 95912.0, 'sum': 783634.0}, 'EL13_pos_1511': {'bp': 74476.0, 'sum': 710987.0}}
COMMENT: RETENTION_TIME_STDEV 0.005
COMMENT: PRECURSOR_M/Z_RAW 86.097069
COMMENT: PRECURSOR_M/Z_STDEV 0.000021
COMMENT: PRECURSOR_IN_MS1 mz 86.096407; int 7.129; delta(ppm) 0.518351
COMMENT: PROPOSED_CHARGE_STATE ND
COMMENT: PROPOSED_ISOTOPE_STATE ND
COMMENT: PROPOSED_MAX_NUM_S 0
COMMENT: PROPOSED_MF SevenGoldenRules 0.306; C5H11N; [M+H]+; delta(ppm) -0.305562
COMMENT: PROPOSED_MF MS-FINDER 3.582; C5H11N; [M+H]+; delta(ppm) -0.311165
COMMENT: PROPOSED_MF SIRIUS5_Sirius 21.487; C5H11N; [M+H]+; delta(ppm) -0.311165
COMMENT: PROPOSED_MF SIRIUS5_Zodiac 1.000; C5H11N; [M+H]+; delta(ppm) -0.311165
COMMENT: PROPOSED_MF SIRIUS6_Sirius 40.046; C5H11N; [M+H]+; delta(ppm) -0.311165
COMMENT: PROPOSED_MF SIRIUS6_Zodiac 1.000; C5H11N; [M+H]+; delta(ppm) -0.311165
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.907; NQRYJNQNLNOLGT-UHFFFAOYSA-N; [M+H]+; C1CCNCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.857; AVFZOVWCLRSYKC-UHFFFAOYSA-N; [M+H]+; CN1CCCC1
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.775; NISGSNTVMOOSJQ-UHFFFAOYSA-N; [M+H]+; C1CCC(C1)N
COMMENT: PROPOSED_COMPOUND CFM-ID:MsfinderDB 0.511; FQIMPUOQPQNHRX-UHFFFAOYSA-N; [M+H]+; N(=CC(C)C)C
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.455; NQRYJNQNLNOLGT-UHFFFAOYSA-N; [M+H]+; Piperidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 6.149; AVFZOVWCLRSYKC-UHFFFAOYSA-N; [M+H]+; N-Methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.899; NISGSNTVMOOSJQ-UHFFFAOYSA-N; [M+H]+; cyclopentanamine
COMMENT: PROPOSED_COMPOUND MS-FINDER:MsfinderDB 5.689; FQIMPUOQPQNHRX-UHFFFAOYSA-N; [M+H]+; methyl(2-methylpropylidene)amine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 1.000; NISGSNTVMOOSJQ-UHFFFAOYSA-N; [M+H]+; cyclopentanamine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.860; NQRYJNQNLNOLGT-UHFFFAOYSA-N; [M+H]+; Piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.609; AVFZOVWCLRSYKC-UHFFFAOYSA-N; [M+H]+; N-Methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:MsfinderDB 0.590; FQIMPUOQPQNHRX-UHFFFAOYSA-N; [M+H]+; methyl(2-methylpropylidene)amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 3.716; NQRYJNQNLNOLGT-UHFFFAOYSA-N; [M+H]+; piperidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.720; AVFZOVWCLRSYKC-UHFFFAOYSA-N; [M+H]+; 1-methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.689; NISGSNTVMOOSJQ-UHFFFAOYSA-N; [M+H]+; cyclopentanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.224; RGHPCLZJAFCTIK-UHFFFAOYSA-N; [M+H]+; 2-methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.125; IAWXHEPLJXAMSG-ONEGZZNKSA-N; [M+H]+; (E)-pent-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.117; GAZWKJNMLLGPKV-UHFFFAOYSA-N; [M+H]+; 2-ethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.086; RBRPAKDHMRWACJ-UHFFFAOYSA-N; [M+H]+; 2-methylbut-3-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.073; BPIDLOWRIYHHBQ-UHFFFAOYSA-N; [M+H]+; pent-4-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.034; VWJYDONMXDIHNY-NSCUHMNNSA-N; [M+H]+; (E)-pent-3-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; NIJMHZCHTZXLJX-UHFFFAOYSA-N; [M+H]+; (1-methylcyclopropyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.017; IXCXVGWKYIDNOS-UHFFFAOYSA-N; [M+H]+; 1-cyclopropylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.016; BRWRRWXQMCPPRZ-UHFFFAOYSA-N; [M+H]+; (2-methylcyclopropyl)methanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.013; ZAXBVBGWLMVNJN-UHFFFAOYSA-N; [M+H]+; 1-methylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.013; PFCBHFDNVFQUJI-UHFFFAOYSA-N; [M+H]+; 3-methylbut-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.012; FVVGXRJNWIYMNJ-UHFFFAOYSA-N; [M+H]+; 1,2-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.012; FJUWTTDYFTWJLY-QWWZWVQMSA-N; [M+H]+; (2R,3R)-2,3-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.008; GNHDRVDLNQEOPA-UHFFFAOYSA-N; [M+H]+; 3-methylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 1.007; YYMQZXMSPLVJJN-UHFFFAOYSA-N; [M+H]+; 2-methylcyclobutan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.993; IVYCMLREPMLLEO-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.987; NZZNMDNKJVUJAL-UHFFFAOYSA-N; [M+H]+; 2-ethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.986; LQNHRNOPWKZUSN-UHFFFAOYSA-N; [M+H]+; cyclobutylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.981; ZOGZOXRETBBBJI-UHFFFAOYSA-N; [M+H]+; 2-cyclopropylethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.975; UVBBCQLPTZEDHT-UHFFFAOYSA-N; [M+H]+; pent-4-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.973; NJTBJCGFHPFCQL-UHFFFAOYSA-N; [M+H]+; 3-methylbut-3-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.914; KYINPWAJIVTFBW-UHFFFAOYSA-N; [M+H]+; 3-methylpyrrolidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.890; KTHMOBNDGBTCLB-UHFFFAOYSA-N; [M+H]+; 2,2-dimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.889; BMVHDBKYVGUEIX-UHFFFAOYSA-N; [M+H]+; 2,3-dimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.887; YPIDADKMTAZBST-UHFFFAOYSA-N; [M+H]+; 2,4-dimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.867; RLVVIGIYIMDCAU-UHFFFAOYSA-N; [M+H]+; 3,3-dimethylazetidine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.861; JHTQHOGTBDMULK-RXMQYKEDSA-N; [M+H]+; (2S)-2-propan-2-ylaziridine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.855; GBCKRQRXNXQQPW-UHFFFAOYSA-N; [M+H]+; N,N-dimethylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.747; PUUULGNNRPBVBA-UHFFFAOYSA-N; [M+H]+; N-ethylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.728; ULEZWUGQDAQWPT-UHFFFAOYSA-N; [M+H]+; N-ethylcyclopropanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.716; PMGNVDPARHYFIN-UHFFFAOYSA-N; [M+H]+; N-methylbut-3-en-2-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.703; QKWULNOMHKBBLA-UHFFFAOYSA-N; [M+H]+; N-methylbut-3-en-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.699; RSUCYDXEFFBUSN-UHFFFAOYSA-N; [M+H]+; N-tert-butylmethanimine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.646; BFPMCZWKUSUMKE-UHFFFAOYSA-N; [M+H]+; 1-cyclopropyl-N-methylmethanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.646; JSIGUUUNVYUWQT-UHFFFAOYSA-N; [M+H]+; N-methylcyclobutanamine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.644; KYTQSTIMXRWCDS-UHFFFAOYSA-N; [M+H]+; N,1-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.643; RHJITQJBHCWZLJ-RFZPGFLSSA-N; [M+H]+; (1R,2R)-N,2-dimethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND MetFrag:PubchemLite 0.629; NOBVTKCADZWKHR-UHFFFAOYSA-N; [M+H]+; N,2-dimethylprop-2-en-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -19.487; NQRYJNQNLNOLGT; [M+H]+; Cypentil
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -55.735; LQNHRNOPWKZUSN; [M+H]+; cyclobutylmethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -61.319; RGHPCLZJAFCTIK; [M+H]+; 2-Methyl-pyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -66.273; PUUULGNNRPBVBA; [M+H]+; Allylethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -71.256; NISGSNTVMOOSJQ; [M+H]+; Cyclopentanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -72.223; BFPMCZWKUSUMKE; [M+H]+; Ambcb4033531
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -74.780; UVBBCQLPTZEDHT; [M+H]+; 4-Penten-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -77.683; JSIGUUUNVYUWQT; [M+H]+; N-methylcyclobutanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -78.709; ZOGZOXRETBBBJI; [M+H]+; Cyclopropaneethanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -84.978; IXCXVGWKYIDNOS; [M+H]+; ACMC-20apfx
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -92.463; AVFZOVWCLRSYKC; [M+H]+; Methylpyrrolidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -111.306; PFCBHFDNVFQUJI; [M+H]+; N-Allyldimethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -111.686; YPIDADKMTAZBST; [M+H]+; (2R,4R)-2,4-dimethylazetidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -113.132; GAZWKJNMLLGPKV; [M+H]+; 2-ethylcyclopropan-1-amine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -124.473; KTHMOBNDGBTCLB; [M+H]+; 2,2-Dimethylazetidine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -134.758; ZAXBVBGWLMVNJN; [M+H]+; 1-Methylcyclobutanamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -141.054; GBCKRQRXNXQQPW; [M+H]+; Allyldimethylamine
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -149.782; YZCRWWDMRZKXNS; [M+H]+; nan
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -154.302; PPJWCUOWPVSSSW; [M+H]+; ethenyl(trimethyl)azanium
COMMENT: PROPOSED_COMPOUND SIRIUS5_CSI:biodatabase -189.390; RSUCYDXEFFBUSN; [M+H]+; tert-Butylazomethine
COMMENT: PROPOSED_COMPOUND SIRIUS5_Confidence:biodatabase 0.696; NQRYJNQNLNOLGT; [M+H]+; Cypentil
COMMENT: CONFIDENCE Level 3: Tentative candidate, Piperidine, NQRYJNQNLNOLGT-UHFFFAOYSA-N; Proposed by SIRIUS5_Confidence with FDR < 0.1; Supported by other software with ranking <= 10 CFM-ID:MsfinderDB (1), MS-FINDER:MsfinderDB (1), MetFrag:MsfinderDB (2), MetFrag:PubchemLite (1); This structural isomer was suggested from the biological context HMDB HMDB0034301;
CH$NAME: Piperidine
CH$NAME: piperidine
CH$COMPOUND_CLASS: Natural product
CH$FORMULA: C5H11N
CH$EXACT_MASS: 85.089149
CH$SMILES: C1CCNCC1
CH$IUPAC: InChI=1S/C5H11N/c1-2-4-6-5-3-1/h6H,1-5H2
CH$LINK: CHEBI CHEBI:18049
CH$LINK: HMDB HMDB0034301
CH$LINK: INCHIKEY NQRYJNQNLNOLGT-UHFFFAOYSA-N
CH$LINK: PUBCHEM CID:8082
SP$SCIENTIFIC_NAME: Homo sapiens
SP$LINK: NCBI-TAXONOMY 9606 
SP$SAMPLE: Cell
AC$INSTRUMENT: Vanquish Flex UHPLC system, Thermo Fisher Scientific - Orbitrap Q Exactive Plus mass spectrometer, Thermo Fisher Scientific
AC$INSTRUMENT_TYPE: LC-ESI-QFT
AC$MASS_SPECTROMETRY: MS_TYPE MS2
AC$MASS_SPECTROMETRY: ION_MODE POSITIVE
AC$MASS_SPECTROMETRY: COLLISION_ENERGY Ramped collision energies of 40 V
AC$MASS_SPECTROMETRY: FRAGMENTATION_MODE CID
AC$MASS_SPECTROMETRY: ION_SPRAY_VOLTAGE 4.0 kV
AC$MASS_SPECTROMETRY: IONIZATION ESI
AC$MASS_SPECTROMETRY: MASS_ACCURACY MS1(ppm) 5.00; MS2(ppm) 5.00
AC$CHROMATOGRAPHY: COLUMN_NAME ZORBAX Pursuit 3 PFP (3 µm, 2.0 mm x 150 mm; Agilent Technologies)
AC$CHROMATOGRAPHY: FLOW_GRADIENT The gradient profile was linear decrease from 0-25% B from 0-2 min; fast linear increase from 25-35% B from 2-11 min; 95% B hold from 15-20 min;fast linear decrease from 95-0% B from 20-21 min. 
AC$CHROMATOGRAPHY: RETENTION_TIME 2.426
MS$FOCUSED_ION: ION_TYPE [M+H]+
MS$FOCUSED_ION: PRECURSOR_M/Z 86.096399
MS$DATA_PROCESSING: RECALIBRATE Data dependent recalibration using whole DDA dataset
PK$SPLASH: splash10-000i-9000000000-2ae3d9c356cfc144d822
PK$ANNOTATION: m/z int m/z_nocal m/z_std(ppm) int_std cor n annotation
  53.0024663 50.0981 53.003164 1.0943 13.00 0.6107 15 ?
  55.0545265 19.2477 55.055234 1.4168 5.10 0.6440 14 f{C4H7}/5.45ppm,p-C1H5N1
  56.0497566 165.0385 56.050469 0.5709 48.49 0.5956 17 f{C3H6N1}/5.01ppm,p-C2H6
  56.9650511 274.6792 56.965767 0.3686 68.58 0.2132 17 ?
  57.0337572 95.3500 57.034473 0.9117 22.87 0.2672 17 ?
  57.0575660 167.5172 57.058282 0.4907 38.37 0.9559 17 f{C3H7N1}/4.65ppm,p-C2H5
  57.0701176 39.2994 57.070834 0.7535 17.41 -0.1176 17 f{C4H9}/4.22ppm,p-C1H3N1
  58.0653879 254.2348 58.066108 0.3444 53.67 0.7034 17 f{C3H8N1}/4.52ppm,p-C2H4
  58.9952108 48.4400 58.995934 0.8306 16.56 0.5235 16 ?
  59.0493531 43.6154 59.050077 1.0330 19.28 -0.1235 16 ?
  60.0810299 263.1822 60.081757 0.3995 29.43 0.5417 17 f{C3H10N1}/4.23ppm,p-C2H2
  67.0543997 89.3584 67.055141 0.5965 16.44 0.6029 17 f{C5H7}/2.58ppm,p-H5N1
  68.9822946 32.2298 68.983038 0.8988 9.22 0.1618 17 ?
  69.0336235 49.7906 69.034367 0.7967 14.11 -0.0172 17 ?
  69.0700288 501.2232 69.070772 0.3475 96.87 0.9363 17 f{C5H9}/2.20ppm,p-H3N1
  70.0652861 100.1811 70.066029 0.8421 17.21 0.8039 17 f{C4H8N1}/2.29ppm,p-C1H4
  71.0128768 20.9950 71.013620 1.7039 6.49 0.4286 14 ?
  71.9520106 180.8849 71.952754 0.5559 52.27 0.2574 17 ?
  84.0444632 248.9786 84.045179 0.4402 103.30 -0.2647 17 ?
  84.0808545 51.2716 84.081570 1.1180 13.03 0.8088 16 f{C5H10N1}/0.94ppm,p-H2
  84.9597500 439.4503 84.960462 0.2589 108.39 0.4681 17 ?
  85.0284573 321.2558 85.029169 0.4587 70.67 0.3799 17 ?
  85.0396486 36.2262 85.040360 1.1406 13.03 -0.2893 15 ?
  85.0478129 34.9782 85.048524 0.8819 18.26 -0.1297 14 ?
  85.0648452 80.6077 85.065556 1.1756 22.40 -0.0858 17 ?
  86.0600944 297.4962 86.060801 0.4416 73.49 0.5245 17 ?
  86.0964734 869.5420 86.097180 0.2788 169.61 1.0000 17 f{C5H12N1}/0.55ppm,p
  86.9927583 38.9351 86.993461 1.0346 12.41 0.3118 16 ?
  87.0441020 199.2911 87.044804 0.7008 49.16 0.1446 17 ?
  87.0553909 43.4608 87.056093 1.0109 13.77 -0.0564 17 ?
  87.0917141 356.6945 87.092416 0.3674 105.23 0.8113 17 ?
  88.0215723 73.2074 88.022269 1.3974 16.19 0.5676 16 ?
  88.0393013 29.6074 88.039998 1.4085 13.01 -0.1329 12 ?
  88.0757367 60.4273 88.076433 0.9197 17.79 -0.0809 17 ?
  88.1121175 999.0000 88.112814 0.2383 49.85 0.5980 17 ?
  102.9702470 35.3319 102.970832 1.1168 9.43 0.1147 16 ?
PK$NUM_PEAK: 36
PK$PEAK: m/z int. rel.int.
  53.002466 50.10 50
  55.054527 19.25 19
  56.049757 165.04 165
  56.965051 274.68 274
  57.033757 95.35 95
  57.057566 167.52 167
  57.070118 39.30 39
  58.065388 254.23 254
  58.995211 48.44 48
  59.049353 43.62 43
  60.081030 263.18 263
  67.054400 89.36 89
  68.982295 32.23 32
  69.033624 49.79 49
  69.070029 501.22 501
  70.065286 100.18 100
  71.012877 21.00 20
  71.952011 180.88 180
  84.044463 248.98 248
  84.080855 51.27 51
  84.959750 439.45 439
  85.028457 321.26 321
  85.039649 36.23 36
  85.047813 34.98 34
  85.064845 80.61 80
  86.060094 297.50 297
  86.096473 869.54 869
  86.992758 38.94 38
  87.044102 199.29 199
  87.055391 43.46 43
  87.091714 356.69 356
  88.021572 73.21 73
  88.039301 29.61 29
  88.075737 60.43 60
  88.112118 999.00 999
  102.970247 35.33 35
//
